These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12900950)

  • 1. Pharmacological treatment of social anxiety disorder: a meta-analysis.
    Blanco C; Schneier FR; Schmidt A; Blanco-Jerez CR; Marshall RD; Sánchez-Lacay A; Liebowitz MR
    Depress Anxiety; 2003; 18(1):29-40. PubMed ID: 12900950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for social phobia.
    Stein DJ; Ipser JC; Balkom AJ
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001206. PubMed ID: 15495010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of social anxiety disorder.
    Blanco C; Antia SX; Liebowitz MR
    Biol Psychiatry; 2002 Jan; 51(1):109-20. PubMed ID: 11801236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panic disorder and social phobia: current treatments and new strategies.
    Davidson JR; Connor KM; Sutherland SM
    Cleve Clin J Med; 1998; 65 Suppl 1():SI39-44; discussion SI45-7. PubMed ID: 12033205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).
    Versiani M
    World J Biol Psychiatry; 2000 Jan; 1(1):27-33. PubMed ID: 12607230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of social phobia with antidepressants.
    Schneier FR
    J Clin Psychiatry; 2001; 62 Suppl 1():43-8; discussion 49. PubMed ID: 11206033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New uses for antidepressants: social phobia.
    Keck PE; McElroy SL
    J Clin Psychiatry; 1997; 58 Suppl 14():32-6; discussion 37-8. PubMed ID: 9418744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evidence-based pharmacotherapy of social anxiety disorder.
    Blanco C; Bragdon LB; Schneier FR; Liebowitz MR
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):235-49. PubMed ID: 22436306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.
    Fahlén T; Nilsson HL; Borg K; Humble M; Pauli U
    Acta Psychiatr Scand; 1995 Nov; 92(5):351-8. PubMed ID: 8619339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperhidrosis in social anxiety disorder.
    Davidson JR; Foa EB; Connor KM; Churchill LE
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1327-31. PubMed ID: 12502021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of social anxiety disorder.
    Ganasen KA; Stein DJ
    Curr Top Behav Neurosci; 2010; 2():487-503. PubMed ID: 21309123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facing the challenge of social anxiety disorder.
    Westenberg HG
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S93-9. PubMed ID: 10523064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
    Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
    Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
    Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
    JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication therapy for social phobia.
    Marshall RD; Schneier FR; Fallon BA; Feerick J; Liebowitz MR
    J Clin Psychiatry; 1994 Jun; 55 Suppl():33-7. PubMed ID: 8077172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis.
    Houghton KT; Forrest A; Awad A; Atkinson LZ; Stockton S; Harrison PJ; Geddes JR; Cipriani A
    BMJ Open; 2017 Mar; 7(3):e013433. PubMed ID: 28348186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.